O'SHAUGHNESSY ASSET MANAGEMENT, LLC
Position in BDTX — Black Diamond Therapeutics, Inc.
CIK 1423442
Stamford, CT
Position in BDTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$388,162
-$473,161 QoQ
Shares Held
182,236
-48.6% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026O'SHAUGHNESSY ASSET MANAGEMENT, LLC holds $95,217,469 across 37 Biotechnology names. BDTX ranks #27 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
61,867 | $27,626,090 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,256 | $10,242,115 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
1,138,169 | $7,272,899 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
34,435 | $6,509,936 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
414,019 | $6,135,761 | |
| 6 | EXEL |
Exelixis, Inc.
|
129,866 | $5,569,952 | |
| 7 | ARGX |
Argenx SE
|
5,055 | $3,691,413 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
125,662 | $3,397,900 |
All Filings in BDTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $388,162 | 182,236 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $861,323 | 354,454 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $539,843 | 142,439 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||